Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE Trial.
暂无分享，去创建一个
J. S. St. John | A. Lincoff | S. Nissen | E. McErlean | S. Nicholls | R. Puri | L. Cho | K. Wolski | J. Riesmeyer | G. Ruotolo | B. Arsenault | S. Nissen | V. Menon | A. Lincoff